Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.divislabs.com | |
Market Cap | 74,497.12 Cr. | |
Enterprise Value(EV) | 71,160.50 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 90.30 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | 31.11 | Trailing Twelve Months Ending 2022-12 |
Industry PE | 31.87 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 498.39 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 5.64 | Calculated using Price: 2,809.00 |
Dividend Yield | 1.07 | Period Ending 2022-03 |
No. of Shares Subscribed | 26.55 Cr. | 265,468,580 Shares |
FaceValue | 2 | |
Company Profile | ||
The Company is engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management. |
1 Day |
|
+0.28% |
1 Week |
|
+0.68% |
1 Month |
|
-3.65% |
3 Month |
|
-19.67% |
6 Month |
|
-22.87% |
1 Year |
|
-37.52% |
2 Year |
|
-19.36% |
5 Year |
|
+171.28% |
10 Year |
|
+462.53% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 28.31 | 26.37 | 28.91 | 21.98 | 15.55 | 21.00 | 19.30 | 23.90 | 28.16 | |
Return on Capital Employed (%) | 36.04 | 33.06 | 35.57 | 28.75 | 21.68 | 28.50 | 25.36 | 32.07 | 35.06 | |
Return on Assets (%) | 19.92 | 18.21 | 22.49 | 17.21 | 11.12 | 15.78 | 15.11 | 19.07 | 22.77 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 2,963 | 3,495 | 4,293 | 5,357 | 5,925 | 6,957 | 7,310 | 9,295 | 11,728 | 12,135 | |
Non Curr. Liab. | 650 | 842 | 85 | 1,412 | 1,769 | 991 | 295 | 364 | 437 | 456 | |
Curr. Liab. | 627 | 776 | 520 | 659 | 653 | 847 | 1,821 | 1,728 | 2,454 | 914 | |
Minority Int. | |||||||||||
Equity & Liab. | 4,241 | 5,112 | 4,898 | 7,429 | 8,347 | 8,795 | 9,425 | 11,387 | 14,619 | 13,505 | |
Non Curr. Assets | 1,984 | 2,340 | 1,871 | 3,418 | 3,812 | 4,145 | 3,851 | 4,596 | 5,009 | 5,075 | |
Curr. Assets | 2,256 | 2,772 | 3,027 | 4,011 | 4,535 | 4,650 | 5,574 | 6,791 | 9,610 | 8,430 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 4,241 | 5,112 | 4,898 | 7,429 | 8,347 | 8,795 | 9,425 | 11,387 | 14,619 | 13,505 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 2,532 | 3,115 | 3,776 | 4,064 | 3,891 | 4,946 | 5,394 | 6,969 | 8,960 | 8,335 | |
Other Income | 71 | 45 | 97 | 75 | 113 | 156 | 190 | 63 | 116 | 335 | |
Total Income | 2,603 | 3,160 | 3,874 | 4,139 | 4,005 | 5,102 | 5,584 | 7,032 | 9,076 | 8,670 | |
Total Expenditure | -1,517 | -1,949 | -2,358 | -2,617 | -2,629 | -3,073 | -3,571 | -4,108 | -5,079 | -5,355 | |
PBIDT | 1,086 | 1,211 | 1,516 | 1,522 | 1,376 | 2,029 | 2,013 | 2,924 | 3,997 | 3,316 | |
Interest | -3 | -3 | -5 | -3 | -2 | -5 | -7 | -2 | -2 | -1 | |
Depreciation | -92 | -136 | -118 | -123 | -142 | -169 | -186 | -256 | -312 | -337 | |
Taxation | -218 | -221 | -267 | -335 | -354 | -502 | -443 | -682 | -723 | -581 | |
Exceptional Items | |||||||||||
PAT | 773 | 852 | 1,126 | 1,060 | 877 | 1,353 | 1,377 | 1,984 | 2,960 | 2,397 | |
Minority Interest | |||||||||||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 773 | 852 | 1,126 | 1,060 | 877 | 1,353 | 1,377 | 1,984 | 2,960 | 2,397 | |
Adjusted EPS | 29 | 32 | 42 | 40 | 33 | 51 | 52 | 75 | 112 | 90 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 480 | 557 | 826 | 1,038 | 1,150 | 776 | 954 | 1,216 | 1,947 | 1,912 | |
Cash Fr. Inv. | -255 | -305 | -521 | -406 | -1,140 | -478 | -685 | -83 | 75 | -2,195 | |
Cash Fr. Finan. | -231 | -249 | -303 | -631 | 2 | -314 | -246 | -1,091 | -35 | -532 | |
Net Change | -5 | 3 | 3 | 0 | 13 | -17 | 23 | 41 | 1,987 | -816 | |
Cash & Cash Eqvt | 12 | 15 | 18 | 18 | -4 | -21 | 2 | 43 | 2,030 | 1,215 |
Sat, 11 Mar 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of schedule of investors meeting to be held on 13.03.2023. |
Wed, 08 Feb 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for SBI Funds Management Ltd |
Wed, 08 Feb 2023
Announcement under Regulation 30 (LODR)-Earnings Call Transcript Transcript of Q3FY23 earnings conference call held on February 03 2023 |
Fri, 24 Mar 2023 |
|
|
|
|
|